Aracari Biosciences
Aracari Biosciences’ propriety human Vascularized Micro-Organ (VMO) technology is the first to grow living, perfusable, human blood vessels within a microfluidic 3D platform. Growth of microtumors in these networks recapitulates the physiological delivery of nutrients, drug compounds, or immune cells through living blood vessels, providing a powerful tool for oncology and immune-oncology applications. At Aracari we collaborate with pharmaceutical clients to more accurately and efficiently test drug compounds to de-risk costly preclinical and clinical failures.